{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/10348"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/10348","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"The Association of Antiretroviral Therapy and Hypertension among HIV-positive Individuals in Canada and Tanzania","abstract":"<p><strong>Introduction: </strong>Hypertension is an important worldwide public health concern and is a concomitant risk factor for brain, kidney and cardiovascular disease, such as myocardial infarction (MI). Highly Active Antiretroviral Therapy (HAART) has greatly increased life expectancy of HIV-positive persons, but has been associated with adverse effects.</p> <p><strong>Objectives: </strong>To assess the association between antiretroviral therapy and incident hypertension; to estimate the incidence of hypertension; and to explore known and potential risk factors for hypertension among HIV-positive individuals in Tanzania and Canada.</p> <p><strong>Methods: </strong>Subjects, 18 years and older, were enrolled into two retrospective cohort studies in Tanzania and Canada. Population and descriptive characteristics were summarized. Hypertension was defined as having a SBP>140 mmHg, DBP>90 mmHg, a diagnosis of high blood pressure, or receiving antihypertensive therapy. Statistical analyses, including independent t-tests, Chi-square tests, multiple linear regression, multivariable logistic and Cox regression were performed to assess for statistical significance (p<0.05) in SPSS14.0.</p> <p><strong>Results: </strong>In Tanzania, 52 HIV-positive, normotensive subjects initiating antiretroviral therapy were enrolled. Subjects had a mean age (SD) of 39.5 (7.9) years, were predominantly Black and 53.8% were male. After one year, 4 (7.7%, 95% CI: 2.1-18.7%) developed hypertension. Blood pressure, weight and body mass index (BMI) significantly increased (p<0.05) by 12 months.</p> <p>In Canada, 486 HIV-positive and normotensive subjects were enrolled; 303 (62.3%) initiated antiretroviral therapy and 183 (37.7%) remained ARV-naive during the study. Subjects were predominantly White (>70%) and male (>75%) with a mean age (SD) of 45.1 (10.0) years. Nine-year incidence of hypertension for ARV-treated and ARV-naïve cohorts was 12.5% (95% CI: 8.8-16.2%) and 8.2% (95% CI: 4.2-12.2%) respectively. Hypertensive individuals were significantly older, heavier, and more likely to have abnormal lipids.</p> <p>In the final multivariable Cox regression model for incident hypertension, antiretroviral therapy was associated with a 125% increased risk (p=0.018), adjusted for age, sex and race. Individuals >50 compared to <40 years had an increased risk of approximately>280% (p=0.003). Current weight (10 kg increments) was associated with a 37% increased risk (p<0.001). An inverse association between CD4-T-lymphocyte count change and hypertension was observed: a positive change of >500 cell/ml compared to a decrease in CD4-T-lymphocyte count was associated with an 80% lower risk (p=0.032).</p> <p><strong> </strong></p> <p><strong>Conclusion: </strong>Hypertension is common among HIV-positive individuals in Tanzania and Canada and expected to increase over time. Hypertension is associated with antiretroviral therapy; however, further research is needed to understand this relationship.<strong> </strong></p>","abstract_html":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Hypertension is an important worldwide public health concern and is a concomitant risk factor for brain, kidney and cardiovascular disease, such as myocardial infarction (MI). Highly Active Antiretroviral Therapy (HAART) has greatly increased life expectancy of HIV-positive persons, but has been associated with adverse effects.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To assess the association between antiretroviral therapy and incident hypertension; to estimate the incidence of hypertension; and to explore known and potential risk factors for hypertension among HIV-positive individuals in Tanzania and Canada.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Subjects, 18 years and older, were enrolled into two retrospective cohort studies in Tanzania and Canada. Population and descriptive characteristics were summarized. Hypertension was defined as having a SBP&gt;140 mmHg, DBP&gt;90 mmHg, a diagnosis of high blood pressure, or receiving antihypertensive therapy. Statistical analyses, including independent t-tests, Chi-square tests, multiple linear regression, multivariable logistic and Cox regression were performed to assess for statistical significance (p&lt;0.05) in SPSS14.0.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In Tanzania, 52 HIV-positive, normotensive subjects initiating antiretroviral therapy were enrolled. Subjects had a mean age (SD) of 39.5 (7.9) years, were predominantly Black and 53.8% were male. After one year, 4 (7.7%, 95% CI: 2.1-18.7%) developed hypertension. Blood pressure, weight and body mass index (BMI) significantly increased (p&lt;0.05) by 12 months.&lt;/p&gt; &lt;p&gt;In Canada, 486 HIV-positive and normotensive subjects were enrolled; 303 (62.3%) initiated antiretroviral therapy and 183 (37.7%) remained ARV-naive during the study. Subjects were predominantly White (&gt;70%) and male (&gt;75%) with a mean age (SD) of 45.1 (10.0) years. Nine-year incidence of hypertension for ARV-treated and ARV-naïve cohorts was 12.5% (95% CI: 8.8-16.2%) and 8.2% (95% CI: 4.2-12.2%) respectively. Hypertensive individuals were significantly older, heavier, and more likely to have abnormal lipids.&lt;/p&gt; &lt;p&gt;In the final multivariable Cox regression model for incident hypertension, antiretroviral therapy was associated with a 125% increased risk (p=0.018), adjusted for age, sex and race. Individuals &gt;50 compared to &lt;40 years had an increased risk of approximately&gt;280% (p=0.003). Current weight (10 kg increments) was associated with a 37% increased risk (p&lt;0.001). An inverse association between CD4-T-lymphocyte count change and hypertension was observed: a positive change of &gt;500 cell/ml compared to a decrease in CD4-T-lymphocyte count was associated with an 80% lower risk (p=0.032).&lt;/p&gt; &lt;p&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Hypertension is common among HIV-positive individuals in Tanzania and Canada and expected to increase over time. Hypertension is associated with antiretroviral therapy; however, further research is needed to understand this relationship.&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;","abstract_has_math":false,"creators":["So, Geoffrey"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Clinical Health Sciences (Health Research Methodology)","school":null,"contributors":[],"advisors":["Smieja, Marek"],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-10","date_published":"2011-10","updated_at":"2026-11-18T19:33:38Z","subjects":["Clinical Epidemiology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/14663"],"render_values":[{"text":"https://doi.org/10.71548/14663","href":"https://doi.org/10.71548/14663","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/5397","6413","2101476"],"render_values":[{"text":"opendissertations/5397","href":null,"code":true},{"text":"6413","href":null,"code":true},{"text":"2101476","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/10348","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/10348","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F10348","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Smieja, Marek"]},{"key":"dc:contributor.department","label":"Department","values":["Clinical Health Sciences (Health Research Methodology)"]},{"key":"dc:creator","label":"Author","values":["So, Geoffrey"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:50:57Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:50:57Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2011-10"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Clinical Epidemiology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/5397","6413","2101476"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/10348","https://doi.org/10.71548/14663"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p><strong>Introduction: </strong>Hypertension is an important worldwide public health concern and is a concomitant risk factor for brain, kidney and cardiovascular disease, such as myocardial infarction (MI). Highly Active Antiretroviral Therapy (HAART) has greatly increased life expectancy of HIV-positive persons, but has been associated with adverse effects.</p> <p><strong>Objectives: </strong>To assess the association between antiretroviral therapy and incident hypertension; to estimate the incidence of hypertension; and to explore known and potential risk factors for hypertension among HIV-positive individuals in Tanzania and Canada.</p> <p><strong>Methods: </strong>Subjects, 18 years and older, were enrolled into two retrospective cohort studies in Tanzania and Canada. Population and descriptive characteristics were summarized. Hypertension was defined as having a SBP>140 mmHg, DBP>90 mmHg, a diagnosis of high blood pressure, or receiving antihypertensive therapy. Statistical analyses, including independent t-tests, Chi-square tests, multiple linear regression, multivariable logistic and Cox regression were performed to assess for statistical significance (p<0.05) in SPSS14.0.</p> <p><strong>Results: </strong>In Tanzania, 52 HIV-positive, normotensive subjects initiating antiretroviral therapy were enrolled. Subjects had a mean age (SD) of 39.5 (7.9) years, were predominantly Black and 53.8% were male. After one year, 4 (7.7%, 95% CI: 2.1-18.7%) developed hypertension. Blood pressure, weight and body mass index (BMI) significantly increased (p<0.05) by 12 months.</p> <p>In Canada, 486 HIV-positive and normotensive subjects were enrolled; 303 (62.3%) initiated antiretroviral therapy and 183 (37.7%) remained ARV-naive during the study. Subjects were predominantly White (>70%) and male (>75%) with a mean age (SD) of 45.1 (10.0) years. Nine-year incidence of hypertension for ARV-treated and ARV-naïve cohorts was 12.5% (95% CI: 8.8-16.2%) and 8.2% (95% CI: 4.2-12.2%) respectively. Hypertensive individuals were significantly older, heavier, and more likely to have abnormal lipids.</p> <p>In the final multivariable Cox regression model for incident hypertension, antiretroviral therapy was associated with a 125% increased risk (p=0.018), adjusted for age, sex and race. Individuals >50 compared to <40 years had an increased risk of approximately>280% (p=0.003). Current weight (10 kg increments) was associated with a 37% increased risk (p<0.001). An inverse association between CD4-T-lymphocyte count change and hypertension was observed: a positive change of >500 cell/ml compared to a decrease in CD4-T-lymphocyte count was associated with an 80% lower risk (p=0.032).</p> <p><strong> </strong></p> <p><strong>Conclusion: </strong>Hypertension is common among HIV-positive individuals in Tanzania and Canada and expected to increase over time. Hypertension is associated with antiretroviral therapy; however, further research is needed to understand this relationship.<strong> </strong></p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["The Association of Antiretroviral Therapy and Hypertension among HIV-positive Individuals in Canada and Tanzania"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Smieja, Marek"],"dc:contributor.department":["Clinical Health Sciences (Health Research Methodology)"],"dc:creator":["So, Geoffrey"],"dc:date.accessioned":["2014-06-18T16:50:57Z"],"dc:date.available":["2014-06-18T16:50:57Z"],"dc:date.created":["2011-07-14"],"dc:date.issued":["2011-10"],"dc:description.abstract":["<p><strong>Introduction: </strong>Hypertension is an important worldwide public health concern and is a concomitant risk factor for brain, kidney and cardiovascular disease, such as myocardial infarction (MI). Highly Active Antiretroviral Therapy (HAART) has greatly increased life expectancy of HIV-positive persons, but has been associated with adverse effects.</p> <p><strong>Objectives: </strong>To assess the association between antiretroviral therapy and incident hypertension; to estimate the incidence of hypertension; and to explore known and potential risk factors for hypertension among HIV-positive individuals in Tanzania and Canada.</p> <p><strong>Methods: </strong>Subjects, 18 years and older, were enrolled into two retrospective cohort studies in Tanzania and Canada. Population and descriptive characteristics were summarized. Hypertension was defined as having a SBP>140 mmHg, DBP>90 mmHg, a diagnosis of high blood pressure, or receiving antihypertensive therapy. Statistical analyses, including independent t-tests, Chi-square tests, multiple linear regression, multivariable logistic and Cox regression were performed to assess for statistical significance (p<0.05) in SPSS14.0.</p> <p><strong>Results: </strong>In Tanzania, 52 HIV-positive, normotensive subjects initiating antiretroviral therapy were enrolled. Subjects had a mean age (SD) of 39.5 (7.9) years, were predominantly Black and 53.8% were male. After one year, 4 (7.7%, 95% CI: 2.1-18.7%) developed hypertension. Blood pressure, weight and body mass index (BMI) significantly increased (p<0.05) by 12 months.</p> <p>In Canada, 486 HIV-positive and normotensive subjects were enrolled; 303 (62.3%) initiated antiretroviral therapy and 183 (37.7%) remained ARV-naive during the study. Subjects were predominantly White (>70%) and male (>75%) with a mean age (SD) of 45.1 (10.0) years. Nine-year incidence of hypertension for ARV-treated and ARV-naïve cohorts was 12.5% (95% CI: 8.8-16.2%) and 8.2% (95% CI: 4.2-12.2%) respectively. Hypertensive individuals were significantly older, heavier, and more likely to have abnormal lipids.</p> <p>In the final multivariable Cox regression model for incident hypertension, antiretroviral therapy was associated with a 125% increased risk (p=0.018), adjusted for age, sex and race. Individuals >50 compared to <40 years had an increased risk of approximately>280% (p=0.003). Current weight (10 kg increments) was associated with a 37% increased risk (p<0.001). An inverse association between CD4-T-lymphocyte count change and hypertension was observed: a positive change of >500 cell/ml compared to a decrease in CD4-T-lymphocyte count was associated with an 80% lower risk (p=0.032).</p> <p><strong> </strong></p> <p><strong>Conclusion: </strong>Hypertension is common among HIV-positive individuals in Tanzania and Canada and expected to increase over time. Hypertension is associated with antiretroviral therapy; however, further research is needed to understand this relationship.<strong> </strong></p>"],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.other":["opendissertations/5397","6413","2101476"],"dc:identifier.uri":["http://hdl.handle.net/11375/10348","https://doi.org/10.71548/14663"],"dc:subject":["Clinical Epidemiology"],"dc:title":["The Association of Antiretroviral Therapy and Hypertension among HIV-positive Individuals in Canada and Tanzania"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:33:38Z"}